SAN DIEGO, Sept. 21, 2021 /PRNewswire/ -- Heron
Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology
company focused on improving the lives of patients by developing
best-in-class treatments to address some of the most important
unmet patient needs, today announced that Barry Quart,
Pharm.D., Chairman and Chief Executive Officer, and John Poyhonen, President and Chief Commercial
Officer, will participate in a fireside chat at the 2021 Cantor
Virtual Global Healthcare Conference on Monday, September 27, 2021 at 1:20 pm ET.
A live webcast of the fireside chat will be available on the
Company's website at www.herontx.com in the Investor Resources
section. A replay of the event will be archived on the
site for 60 days.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage
biotechnology company focused on improving the lives of patients by
developing best-in-class treatments to address some of the most
important unmet patient needs. Our advanced science, patented
technologies, and innovative approach to drug discovery and
development have allowed us to create and commercialize a portfolio
of products that aim to advance the standard-of-care for acute care
and oncology patients. For more information,
visit www.herontx.com.
Forward-Looking Statements
This news release contains "forward-looking statements" as
defined by the Private Securities Litigation Reform Act of 1995.
Heron cautions readers that forward-looking statements are based on
management's expectations and assumptions as of the date of this
news release and are subject to certain risks and uncertainties
that could cause actual results to differ materially. These risks
and uncertainties include, but are not limited to, risks and
uncertainties identified in the Company's filings with the
Securities and Exchange Commission. Forward-looking statements
reflect our analysis only on their stated date, and Heron takes no
obligation to update or revise these statements except as may be
required by law.
Investor Relations and Media Contact: David Szekeres, Executive Vice President, Chief
Operating Officer, Heron Therapeutics, Inc., dszekeres@herontx.com,
858-251-4447
View original
content:https://www.prnewswire.com/news-releases/heron-therapeutics-to-present-at-the-2021-cantor-virtual-global-healthcare-conference-301381949.html
SOURCE Heron Therapeutics, Inc.